Afya Limited SEC filings document the company as a foreign private issuer reporting on Form 6-K and presenting financial information in Brazilian reais under IFRS. The filings include unaudited interim and annual consolidated financial statements, operating-result releases and balance-sheet disclosures covering cash, receivables, property and equipment, right-of-use assets, intangible assets, loans and financing, lease liabilities and accounts payable to selling shareholders.
The filing record also documents Afya’s capital-allocation actions, including dividend approvals and share repurchase disclosures, as well as medical-seat authorizations for Brazilian campuses and board-governance changes. These reports connect Afya’s education and medical practice solutions business with formal disclosures on capital structure, liquidity, campus approvals, ownership-related obligations and governance matters.
Afya Limited filed a Form 6-K reporting an operational update. The company announced a medical seats increase at AFYA Faculdade de Ciências Médicas Bragança, as noted in Exhibit 99.1.
The report was signed by Chief Executive Officer Virgilio Deloy Capobianco Gibbon on November 7, 2025.
Afya Limited filed a Form 6-K as a foreign private issuer for October 2025. The filing highlights an exhibit describing the repurchase of its Series A perpetual convertible preferred shares and the repayment of debentures issued by Afya Participações S.A., signaling adjustments to its capital and financing structure.
Afya Limited, a Brazil-based foreign private issuer, submitted a Form 6-K for August 2025. The filing mainly serves to furnish an exhibit titled "Afya Limited Announces a New Share Repurchase Program," indicating the company has authorized a new program to buy back its own shares. The report is signed on behalf of Afya by its Chief Executive Officer, Virgilio Deloy Capobianco Gibbon.